Navigation Links
Swedish University Hospital Improves Monitoring of Treatment Efficacy in Multiple Sclerosis With Synthetic MRI Innovation
Date:9/1/2011

site since 2009 in order to better understand how the software can be used in clinical practice.

Accelerator Nordic AB is a group of Life Science companies focused on pharmaceutical drug development and medical devices. Accelerator's subsidiaries have exposure towards large growth markets such as cancer therapy, medical imaging and orthopedics. The business model is centered on partnering or out-licensing. Accelerator Nordic is publicly traded on the Aktietorget exchange in Stockholm, Sweden. For more information please visit, http://www.acceleratorab.se.

SyntheticMR AB, a subsidiary to Accelerator Nordic AB, has developed SyMRI Diagnostics, software for more effective Magnetic Resonance Imaging. SyMRI Diagnostics uses a rapid MRI scan that provides a measure for patient tissue properties. Using these properties conventional MRI images and tissue images can be generated. In this way examination time is reduced for the patient and the decision support is improved for the radiologist. For more information, please visit http://www.syntheticmr.se.

Sectra develops and sells IT systems and products for radiology, mammography and orthopaedics. More than 1,100 hospitals, clinics and imaging centers worldwide use the systems daily, together performing over 55 million radiology examinations annually. This makes Sectra one of the world- leading companies within systems for handling digital radiology images. In Scandinavia, Sectra is the market leader with more than 50% of all film-free installations. Sectra's systems have been installed in North America, Scandinavia and most major countries in Europe and the Far East. Sectra was founded in 1978 and has its roots in Linköping University in Sweden. The compa
'/>"/>

SOURCE Accelerator Nordic AB and SyntheticMR AB
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Swedish-American Life Science Summit (SALSS) to Address Major Issues Including Healthcare Reform, Synthetic Biology and Innovative Financing for Biotechs
2. Swedish in Seattle Unveils State-of-the-Art Brain Tumor Center Combining Advanced Treatment With Innovation in Research
3. Swedish Neuroscience Institute and Institute for Systems Biology in Seattle Form Alliance to Learn More about Brain Diseases
4. University of Houston receives NSF grant for high school teachers program
5. New nanoscale parameter by Aalto University resolves dilemmas on silicon property
6. University of Muenster Bridges 1st Patient to Transplant with SynCardias Total Artificial Heart
7. Elsevier and the National University of Singapore Announce Winners of 24-Hour Hackathon
8. The Human Brain is Sensitive to Light, Breakthrough Findings From Valkee and the University of Oulu
9. CEM President and CEO Delivers Commencement Address at the University of Texas at Austin Chemistry and Biochemistry Department Graduation
10. Computerized system to prevent SIDS developed by Ben-Gurion University students
11. University of Dayton Study Overturns 250-Year-Old Belief About Effects of Age, Repeated Injury on Tissue Regeneration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... (PRWEB) December 17, 2014 Gene ... that it has entered into a technology access ... (ADM) to apply DNA2.0’s proprietary protein engineering technology, ... process. , “We are extremely excited that the ... platform. This proprietary bioengineering technology has now ...
(Date:12/17/2014)... SOUTH SAN FRANCISCO, Calif. , Dec. 17, ... positive results of a Phase 2 study evaluating ... for the treatment of patients with severe, chronic ... the current standard of care, including topical steroids ... endpoint was percent change in Visual Analog Scale ...
(Date:12/15/2014)...  GlassesOff Inc. (OTCBB: GLSO) announced today the appointment ... director of the Company,s Board of Directors. ... its CEO until its acquisition by Stanley Black ... Recognized as the inventor of the first Wi-Fi-based Active ... -based RFID solutions focused on improving operational efficiency, safety ...
(Date:12/13/2014)... (PRWEB) December 12, 2014 Clarassance, a ... announced its new name: Therabron Therapeutics , Inc. ... and bronchioles (a type of structure in the lungs ... company’s mission to develop novel protein therapeutics for the ... directors decided to change the name to mark the ...
Breaking Biology Technology:ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 3Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 4AeroScout Founder Joins GlassesOff's Board of Directors 2AeroScout Founder Joins GlassesOff's Board of Directors 3Maryland-based Biotech Company's Path Forward in Treating Respiratory Diseases Sparks Name Change 2
... Vaccine for Animals to be Produced in Changzhou Hi-Tech ... ... -- A project for,producing inactivated rabies animal vaccines was recently launched ... product developed by a team of leading overseas scientists. It is,reported ...
... (Nasdaq: CVTX ) today reported financial results for the ... March 31, 2008, the Company reported a net loss,of $31.9 ... loss of $34.1,million, or $0.57 per share, for the prior ... share, for the same quarter in 2007., For the ...
... Study in Science, DRESDEN, Germany, April ... of RAFT intervention therapeutics, announced today the,publication ... potential novel strategy,for therapeutic intervention in Alzheimer,s ... the cell membrane (RAFTS). The study conducted,by ...
Cached Biology Technology:Leading Overseas Scientists Establish High-Tech Bio-Pharmaceutical Enterprise in Changzhou 2Leading Overseas Scientists Establish High-Tech Bio-Pharmaceutical Enterprise in Changzhou 3CV Therapeutics Reports 2008 First Quarter Financial Results 2CV Therapeutics Reports 2008 First Quarter Financial Results 3CV Therapeutics Reports 2008 First Quarter Financial Results 4CV Therapeutics Reports 2008 First Quarter Financial Results 5Novel Approach to Treat Alzheimer's and Other Diseases Offered by Targeting Cell Membrane RAFTS 2Novel Approach to Treat Alzheimer's and Other Diseases Offered by Targeting Cell Membrane RAFTS 3Novel Approach to Treat Alzheimer's and Other Diseases Offered by Targeting Cell Membrane RAFTS 4
(Date:11/21/2014)... November 18, 2014 According to ... by Systems (Video, RFID, Access Control, Intrusion Detection, Parking ... Banks, Government), Component Service Geography - Global Forecasts to ... is projected to be around $25 Billion in 2014 ... growing at a CAGR of 8.69%. Browse ...
(Date:11/21/2014)... Calif. , Nov. 20, 2014   Atmel® ... leader in microcontroller (MCU) and touch technology solutions, today ... temperature sensors with the widest V cc ... higher temperature accuracy and faster I 2 C bus ... and serial EEPROM memory making them ideal for consumer, ...
(Date:11/18/2014)... 18, 2014   EyeLock Inc. , a ... MorphoTrust USA (Safran), a leading U.S. ... a strategic partnership to offer comprehensive biometric identity ... (MVA), airport screening and financial services markets. ... serves consumers through a nationwide network of 1,100 ...
Breaking Biology News(10 mins):Industrial Security Systems Market Worth $38 Billion by 2020 2Industrial Security Systems Market Worth $38 Billion by 2020 3Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 2Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 3Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 4EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 2EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 3
... organisms that have different traits yet to study, and ... information from organisms rapidly evolving, the "forest" of evolution ... individual case and detail. A review paper published ... Marvalee Wake and Chelsea Specht, all currently National Science ...
... for clues to improved treatments for some people with schizophrenia ... third of 1 percent of patients. In ... Health, schizophrenia patients were 14 times more likely than controls ... The mutations were in the gene for VIPR2, the receptor ...
... ANAHEIM, Calif., Feb. 24, 2011 For a week ... Los Angeles Angels baseball, and other attractions becomes the world ... gather here for the 241st National Meeting & Exposition of ... members, ACS is the world,s largest scientific society, and the ...
Cached Biology News:Rare gene glitch may hold clues for schizophrenia -- NIH-funded study 2Rare gene glitch may hold clues for schizophrenia -- NIH-funded study 3American Chemical Society National Meeting & Exposition, March 27-31, Anaheim, Calif. 2
Human FADD Affinity Purified Polyclonal Ab...
Human VEGF R3/Flt-4 Phycoerythrin MAb (Clone 54733)...
Immunogen: Synthetic Peptide: V(22) N G H E F E I E G E G E G R(36) Storage: -20 C, Avoid Freeze/Thaw Cycles...
Human beta IG-H3 MAb (Clone 348506) Keywords: BIGH3, betaIG-H3 Protein Family: Extracellular Matrix Molecules...
Biology Products: